Aurobindo buys new U.S. headquarters

By Elaine Rigoli

Tampa, Fla., July 7 - Aurobindo Pharma Ltd. has acquired a Food and Drug Administration-compliant facility in Dayton, N.J., that will serve as the company's U.S. headquarters.

The facility, spread over 20 acres, is comprised of 100,000 square feet of research and development, formulation manufacturing and distribution facilities with potential for future expansion.

Aurobindo is a pharmaceutical company located in Hyderabad, India.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.